242 related articles for article (PubMed ID: 25016060)
1. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression.
Barboro P; Ferrari N; Balbi C
Cancer Lett; 2014 Oct; 352(2):152-9. PubMed ID: 25016060
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression.
Barboro P; Salvi S; Rubagotti A; Boccardo S; Spina B; Truini M; Carmignani G; Introini C; Ferrari N; Boccardo F; Balbi C
Int J Oncol; 2014 May; 44(5):1589-98. PubMed ID: 24626777
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells.
Otoshi T; Tanaka T; Morimoto K; Nakatani T
PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736
[TBL] [Abstract][Full Text] [Related]
4. Role of heterogeneous nuclear ribonucleoprotein K in tumor development.
Chen Y; Zeng Y; Xiao Z; Chen S; Li Y; Zou J; Zeng X
J Cell Biochem; 2019 Sep; 120(9):14296-14305. PubMed ID: 31127648
[TBL] [Abstract][Full Text] [Related]
5. Compartmentalization of hnRNP-K during cell cycle progression and its interaction with calponin in the cytoplasm.
Laury-Kleintop LD; Tresini M; Hammond O
J Cell Biochem; 2005 Aug; 95(5):1042-56. PubMed ID: 15962305
[TBL] [Abstract][Full Text] [Related]
6. Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression.
Lu J; Gao FH
Biomed Rep; 2016 Jun; 4(6):657-663. PubMed ID: 27284403
[TBL] [Abstract][Full Text] [Related]
7. Identification of the methylation preference region in heterogeneous nuclear ribonucleoprotein K by protein arginine methyltransferase 1 and its implication in regulating nuclear/cytoplasmic distribution.
Chang YI; Hsu SC; Chau GY; Huang CY; Sung JS; Hua WK; Lin WJ
Biochem Biophys Res Commun; 2011 Jan; 404(3):865-9. PubMed ID: 21184736
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells.
Sugimasa H; Taniue K; Kurimoto A; Takeda Y; Kawasaki Y; Akiyama T
Biochem Biophys Res Commun; 2015 Mar; 459(1):29-35. PubMed ID: 25701787
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer.
Carpenter B; McKay M; Dundas SR; Lawrie LC; Telfer C; Murray GI
Br J Cancer; 2006 Oct; 95(7):921-7. PubMed ID: 16953238
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells.
Chen LC; Liu HP; Li HP; Hsueh C; Yu JS; Liang CL; Chang YS
Oncogene; 2009 Apr; 28(17):1904-15. PubMed ID: 19330019
[TBL] [Abstract][Full Text] [Related]
11. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.
Kim JH; Hahm B; Kim YK; Choi M; Jang SK
J Mol Biol; 2000 May; 298(3):395-405. PubMed ID: 10772858
[TBL] [Abstract][Full Text] [Related]
12. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors.
Xiao Z; Ko HL; Goh EH; Wang B; Ren EC
Carcinogenesis; 2013 Jul; 34(7):1458-67. PubMed ID: 23455382
[TBL] [Abstract][Full Text] [Related]
13. Characterization of multiple alternative forms of heterogeneous nuclear ribonucleoprotein K by phosphate-affinity electrophoresis.
Kimura Y; Nagata K; Suzuki N; Yokoyama R; Yamanaka Y; Kitamura H; Hirano H; Ohara O
Proteomics; 2010 Nov; 10(21):3884-95. PubMed ID: 20960454
[TBL] [Abstract][Full Text] [Related]
14. Cell-type-specific and developmental regulation of heterogeneous nuclear ribonucleoprotein K mRNA in the rat nervous system.
Blanchette AR; Fuentes Medel YF; Gardner PD
Gene Expr Patterns; 2006 Aug; 6(6):596-606. PubMed ID: 16488668
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS
Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600
[TBL] [Abstract][Full Text] [Related]
16. The transactivation domain of heterogeneous nuclear ribonucleoprotein K overlaps its nuclear shuttling domain.
Chan JY; Huang SM; Liu ST; Huang CH
Int J Biochem Cell Biol; 2008; 40(10):2078-89. PubMed ID: 18346927
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a host factor required for dengue virus and JunÃn virus multiplication.
Brunetti JE; Scolaro LA; Castilla V
Virus Res; 2015 May; 203():84-91. PubMed ID: 25865411
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer.
Yang R; Zeng Y; Xu H; Chen Z; Xiang M; Fu Y; Yin Y; Zhong J; Zeng M; Wang P; You Q; Zeng X
Oncol Rep; 2016 Aug; 36(2):929-35. PubMed ID: 27278897
[TBL] [Abstract][Full Text] [Related]
20. Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma.
Roychoudhury P; Chaudhuri K
Br J Cancer; 2007 Aug; 97(4):574-5; author reply 576. PubMed ID: 17667925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
